Regulation of α1,3galactosyltransferase expression in pig endothelial cells -: Implications for xenotransplantation

被引:4
|
作者
Mercier, D
Charreau, B
Wierinckx, A
Keijser, R
Adriaensens, L
van den Berg, R
Joziasse, DH
机构
[1] Vrije Univ Amsterdam, Ctr Med, Dept Med Pharmacol, Res Inst Neurosci, NL-1081 BT Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Ctr Med, Dept Mol Cell Biol, Res Inst Immunol & Inflammatory Dis, NL-1081 BT Amsterdam, Netherlands
[3] Inst Transplantat & Rech Transplantat, INSERM, U437, Nantes, France
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 2002年 / 269卷 / 05期
关键词
alpha 1,3galactosyltransferase; promoter; pig endothelial cells; regulation; xenotransplantation;
D O I
10.1046/j.1432-1033.2002.02791.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The disaccharide galactosealpha1,3galactose (the alphaGal epitope) is the major xenoantigen responsible for the hyperacute vascular rejection occurring in pig-to-primates organ transplantation. The synthesis of the alphaGal epitope is catalyzed by the enzyme alpha1,3-galactosyltransferase (alpha1,3GalT). To be able to control porcine alpha1,3GalT gene expression specific-ally. we have analyzed the upstream portion of the alpha1,3GalT gene, and identified the regulatory sequences. Porcine alpha1,3GalT transcripts were detected by 5' RACE analysis, and the corresponding genomic sequences were isolated from a phage library. The porcine alpha1,3GalT gene consists of at least 10 different exons, four of which contain 5' untranslated sequence. Four distinct promoters, termed A-D, drive alpha1,3GalT gene transcription in porcine cells. A combination of alternative promoter usage and alternative splicing produces a series of transcripts that differ in their 5' portion, but encode the same protein. Promoters A-C have been isolated. and functionally characterized using luciferase reporter gene assays in transfected porcine endothelial cells (PEC-A). Promoter preference in porcine endothelial cells was estimated on the basis of relative transcript levels as determined by real-time quantitative PCR. More than 90% of the alpha1,3GalT transcripts in PEC-A cells originate from promoter B, which has characteristics of a housekeeping gene promoter. While promoter preference remains unchanged, alpha1,3GalT mRNA levels increase by 50% in 12 h upon tumour necrosis factor alpha-activation of PEC-A cells. However, the magnitude of this change induced by inflammatory conditions could be insufficient to affect cell surface alpha1,3-galactosylation.
引用
收藏
页码:1464 / 1473
页数:10
相关论文
共 50 条
  • [21] Characterization of the substrate specificity of α1,3galactosyltransferase utilizing modified N-acetyllactosamine disaccharides
    Stults, CLM
    Macher, BA
    Bhatti, R
    Srivastava, OP
    Hindsgaul, O
    GLYCOBIOLOGY, 1999, 9 (07) : 661 - 668
  • [22] Complete absence of the αGal xenoantigen and isoglobotrihexosylceramide in α1,3galactosyltransferase knock-out pigs
    Yung, Gisella L. Puga
    Li, Yunsen
    Borsig, Lubor
    Millard, Anne-Laure
    Karpova, Maria B.
    Zhou, Dapeng
    Seebach, Joerg D.
    XENOTRANSPLANTATION, 2012, 19 (03) : 196 - 206
  • [23] Site-directed mutagenesis of glutamate 317 of bovine α-1,3Galactosyltransferase and its effect on enzyme activity:: Implications for reaction mechanism
    Molina, Patricia
    Knegtel, Ronald M. A.
    Macher, Bruce A.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2007, 1770 (08): : 1266 - 1273
  • [24] Inhibition of expression of the Galα1-3Gal epitope on porcine cells using an intracellular single-chain antibody directed against α1,3Galactosyltransferase
    Sepp, A
    Farrar, CA
    Dorling, T
    Cairns, T
    George, AJT
    Lechler, RI
    JOURNAL OF IMMUNOLOGICAL METHODS, 1999, 231 (1-2) : 191 - 205
  • [25] Immunological Compatibility of Bone Tissues from Alpha-1,3-galactosyltransferase Knockout Pig for Xenotransplantation
    Kim, Se Eun
    Kang, Kyung Won
    Gu, Suna
    Hwang, Seongsoo
    Ock, Sun A.
    Shim, Kyung Mi
    Jang, Kwangsik
    Choi, Seok Hwa
    Lee, Sang-Myeong
    Kang, Seong Soo
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [26] In vivo targeting of vaccinating tumor cells to antigen-presenting cells by a gene therapy method with adenovirus containing the α1,3galactosyltransferase gene
    Deriy, L
    Ogawa, H
    Gao, GP
    Galili, U
    CANCER GENE THERAPY, 2005, 12 (06) : 528 - 539
  • [28] Adenovirus-mediated expression of pig α(1,3) galactosyltransferase reconstructs Gal α(1,3) Gal epitope on the surface of human tumor cells
    Xing, L
    Xia, GH
    Fei, J
    Huang, F
    Guo, LH
    CELL RESEARCH, 2001, 11 (02) : 116 - 124
  • [29] In vivo targeting of vaccinating tumor cells to antigen-presenting cells by a gene therapy method with adenovirus containing the α1,3galactosyltransferase gene
    Lucy Deriy
    Haruko Ogawa
    Guang-Ping Gao
    Uri Galili
    Cancer Gene Therapy, 2005, 12 : 528 - 539
  • [30] Adult and neonatal anti-Gal response in knock-out mice for α1,3galactosyltransferase
    LaTemple, DC
    Galili, U
    XENOTRANSPLANTATION, 1998, 5 (03) : 191 - 196